Wait until you learn about the biotech industry, they often go public with no revenue. I don't think there is anything wrong with this though, markets are pricing future growth, which may or may not materialize.
This is why I don't take seriously any stats about pharma R&D spending. They don't consider acquisitions to be R&D even though it often effecively is.